Smoking Cessation Alters Intestinal Microbiota: Insights from Quantitative Investigations on Human Fecal Samples Using FISH
There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we ai...
Saved in:
Published in | Inflammatory bowel diseases Vol. 20; no. 9; pp. 1496 - 1501 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Oxford University Press
01.09.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.MethodsStool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.ResultsIntestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).ConclusionsAs determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis. |
---|---|
AbstractList | There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.
Stool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.
Intestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).
As determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis. BackgroundThere has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.MethodsStool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.ResultsIntestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).ConclusionsAs determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis. Background: There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach. Methods: Stool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups. Results: Intestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria ( beta - and gamma -subgroup of Proteobacteria). Conclusions: As determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis. There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.BACKGROUNDThere has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.Stool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.METHODSStool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.Intestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).RESULTSIntestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).As determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis.CONCLUSIONSAs determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis. There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.MethodsStool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.ResultsIntestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).ConclusionsAs determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis. |
Author | Brülisauer, Karin Zeitz, Jonas Frei, Pascal Rogler, Gerhard Vavricka, Stephan R. Fried, Michael Schuppler, Markus Biedermann, Luc Loessner, Martin J. Scharl, Michael |
Author_xml | – sequence: 1 givenname: Luc surname: Biedermann fullname: Biedermann, Luc organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland – sequence: 2 givenname: Karin surname: Brülisauer fullname: Brülisauer, Karin organization: †Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland – sequence: 3 givenname: Jonas surname: Zeitz fullname: Zeitz, Jonas organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland – sequence: 4 givenname: Pascal surname: Frei fullname: Frei, Pascal organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland – sequence: 5 givenname: Michael surname: Scharl fullname: Scharl, Michael organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland – sequence: 6 givenname: Stephan R. surname: Vavricka fullname: Vavricka, Stephan R. organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland – sequence: 7 givenname: Michael surname: Fried fullname: Fried, Michael organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland – sequence: 8 givenname: Martin J. surname: Loessner fullname: Loessner, Martin J. organization: †Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland – sequence: 9 givenname: Gerhard surname: Rogler fullname: Rogler, Gerhard organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland – sequence: 10 givenname: Markus surname: Schuppler fullname: Schuppler, Markus organization: †Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25072500$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkV1rHCEYhSWk5Kv9B6EIvenNJDo6o-YuWbrdhYRStrkWdZyN6Yxu1QmU_vm62QTK3qSKvKLPOcp7TsGhD94CcI7RBUaCXd4tby7QvwPX4gCc4Ia0FeWUHpY9YrxCQvBjcJrSI0J1meIIHNcNYmWhE_BnNYafzq_hzKaksgseXg_ZxgSXPtuUnVcDvHMmBu1CVlflOLn1Q06wj2GE3yfls8tF-GTL1dNWsX62SbBYLaZReTi3ppis1LgZbIL3afvcfLlavAfvejUk--GlnoH7-Zcfs0V1--3rcnZ9WxmKeK503ykqiLW81twwTDVvGO7blhGlTE90R1THDVa6MUxQLVrKiTa1ol2LbWfIGfi8893E8GsqX5SjS8YOg_I2TEniliPacNGQt9GmIQxxxFlBP-2hj2GKpV1JEtwKJoSgW-rjCzXp0XZyE92o4m_5mkABrnZAaXFK0fbSPPcz-ByVGyRGchu3LHHL_biLmO6JX_3fkF3uZGHa_J_iLwxAuiY |
CitedBy_id | crossref_primary_10_5217_ir_2020_00008 crossref_primary_10_1080_00365521_2023_2255710 crossref_primary_10_1093_ibd_izaa152 crossref_primary_10_3390_metabo12030234 crossref_primary_10_1111_nmo_14157 crossref_primary_10_3389_fimmu_2020_02144 crossref_primary_10_3748_wjg_v21_i37_10609 crossref_primary_10_1097_MPG_0000000000000950 crossref_primary_10_3390_biomedicines12081645 crossref_primary_10_1007_s00415_019_09320_1 crossref_primary_10_1186_s13099_022_00524_x crossref_primary_10_1097_IJ9_0000000000000051 crossref_primary_10_1038_s41467_024_44841_y crossref_primary_10_1186_s12890_024_03045_2 crossref_primary_10_1002_mnfr_202400494 crossref_primary_10_1080_19768354_2024_2338855 crossref_primary_10_1016_j_nmni_2015_11_004 crossref_primary_10_3390_biomedicines11123144 crossref_primary_10_3390_nu12030880 crossref_primary_10_3390_biomedicines11041144 crossref_primary_10_1183_13993003_02320_2019 crossref_primary_10_1136_gutjnl_2019_319630 crossref_primary_10_3389_fmicb_2024_1465673 crossref_primary_10_3390_cancers15123200 crossref_primary_10_1016_S2468_1253_17_30031_6 crossref_primary_10_1038_s41598_021_83922_6 crossref_primary_10_1155_2018_4832912 crossref_primary_10_1016_j_gendis_2016_03_004 crossref_primary_10_1053_j_gastro_2017_05_010 crossref_primary_10_3389_fneur_2019_01155 crossref_primary_10_1007_s10482_020_01474_7 crossref_primary_10_1093_ntr_ntw030 crossref_primary_10_1016_j_disamonth_2017_07_001 crossref_primary_10_3233_JPD_150557 crossref_primary_10_1016_j_jad_2023_02_002 crossref_primary_10_1007_s00384_023_04468_9 crossref_primary_10_1016_j_bpg_2017_09_009 crossref_primary_10_1007_s40618_016_0594_6 crossref_primary_10_1038_d41586_021_03548_6 crossref_primary_10_1177_2397847317741884 crossref_primary_10_1371_journal_pone_0230895 crossref_primary_10_1007_s00203_018_1506_2 crossref_primary_10_3390_nu14091921 crossref_primary_10_1016_j_nut_2020_110797 crossref_primary_10_1007_s10620_019_05648_w crossref_primary_10_1099_jmm_0_000331 crossref_primary_10_1016_j_cgh_2018_08_067 crossref_primary_10_1093_ecco_jcc_jjv113 crossref_primary_10_12998_wjcc_v6_i4_44 crossref_primary_10_1007_s11427_023_2446_y crossref_primary_10_1093_ajcn_nqac128 crossref_primary_10_1007_s40618_019_1010_9 crossref_primary_10_1089_chi_2014_0113 crossref_primary_10_1186_s12889_019_7807_9 crossref_primary_10_1186_s12866_020_01907_3 crossref_primary_10_3748_wjg_v27_i22_2921 crossref_primary_10_1016_j_schres_2020_02_010 crossref_primary_10_1038_s41598_017_13739_9 crossref_primary_10_1016_j_disamonth_2019_02_004 crossref_primary_10_3390_jcm7090282 crossref_primary_10_1097_MIB_0000000000000875 crossref_primary_10_1136_gutjnl_2021_325021 crossref_primary_10_1002_brb3_3130 crossref_primary_10_1099_mic_0_000336 crossref_primary_10_1159_000524181 crossref_primary_10_3389_fnut_2024_1371064 crossref_primary_10_1042_CS20171110 crossref_primary_10_1111_apt_14338 crossref_primary_10_1128_AEM_01753_16 crossref_primary_10_1016_j_cgh_2018_07_012 crossref_primary_10_1016_j_pnpbp_2020_110076 crossref_primary_10_4081_reumatismo_2024_1572 crossref_primary_10_1016_j_lfs_2020_118616 crossref_primary_10_1016_j_suc_2015_07_006 crossref_primary_10_1080_01635581_2024_2367266 crossref_primary_10_1080_19490976_2017_1284733 crossref_primary_10_1042_CS20220175 crossref_primary_10_3390_nu11061398 crossref_primary_10_3389_fnut_2021_642509 crossref_primary_10_5662_wjm_v14_i1_89196 crossref_primary_10_1080_15412555_2021_2019208 crossref_primary_10_3390_ijerph13111075 crossref_primary_10_1016_j_cgh_2017_11_002 crossref_primary_10_1038_s41579_023_00998_9 crossref_primary_10_1183_23120541_00788_2023 crossref_primary_10_3390_jcm10071515 crossref_primary_10_1016_j_jaci_2019_11_003 crossref_primary_10_1038_s41531_023_00511_2 crossref_primary_10_1038_nrgastro_2015_34 crossref_primary_10_1111_apt_15774 crossref_primary_10_1016_j_atherosclerosis_2020_08_028 crossref_primary_10_1038_nrendo_2016_32 crossref_primary_10_1093_ije_dyy298 crossref_primary_10_3390_nu14224800 crossref_primary_10_1007_s40471_018_0167_7 crossref_primary_10_1016_j_cmet_2021_05_005 crossref_primary_10_1016_j_plabm_2017_09_001 crossref_primary_10_1111_resp_12971 crossref_primary_10_1530_EJE_14_0874 crossref_primary_10_7717_peerj_4693 crossref_primary_10_5607_en20047 crossref_primary_10_1007_s00296_015_3368_0 crossref_primary_10_3748_wjg_v26_i25_3611 crossref_primary_10_1152_physrev_00018_2018 crossref_primary_10_1136_bmjopen_2020_040117 crossref_primary_10_3389_fimmu_2018_00074 crossref_primary_10_1007_s00535_015_1064_1 crossref_primary_10_1111_codi_13748 crossref_primary_10_1002_jat_4338 crossref_primary_10_3390_nu15214661 crossref_primary_10_1093_gastro_goab046 crossref_primary_10_1016_j_ebiom_2021_103538 crossref_primary_10_1038_nrmicro_2016_142 crossref_primary_10_1016_j_gtc_2020_07_005 crossref_primary_10_1038_s41586_021_04194_8 crossref_primary_10_3390_ijms24010252 crossref_primary_10_18332_tid_194680 crossref_primary_10_1155_ijcp_5511146 crossref_primary_10_1016_j_anaerobe_2023_102787 crossref_primary_10_1159_000494696 crossref_primary_10_1007_s11892_017_0903_2 crossref_primary_10_1111_jgh_16497 |
Cites_doi | 10.1371/journal.pbio.0060280 10.1053/gast.1996.v110.pm8566589 10.1038/nrmicro1888 10.1136/gut.2005.073817 10.1002/ibd.20828 10.1126/science.1237439 10.1053/j.gastro.2007.04.005 10.1002/cyto.990140205 10.1038/nature11450 10.1128/AEM.61.8.3069-3075.1995 10.1128/AEM.68.6.2982-2990.2002 10.1038/nature11234 10.1126/science.1179721 10.1038/nature05414 10.1007/s10620-009-0934-x 10.1093/oxfordjournals.aje.a009706 10.1099/jmm.0.46498-0 10.1073/pnas.1000087107 10.1002/ibd.21864 10.1128/AEM.64.9.3336-3345.1998 10.1099/00221287-140-10-2849 10.1111/j.1572-0241.2001.03944.x 10.1016/S0167-7012(00)00152-4 10.1073/pnas.1011383107 10.1126/science.276.5313.734 10.1099/13500872-142-5-1097 10.1016/0306-4603(87)90045-1 10.1038/nature10554 10.1128/jb.172.2.762-770.1990 10.1002/hep.26319 10.1073/pnas.0407076101 10.1038/nature12198 10.4065/81.11.1462 10.1136/gut.2010.223263 10.1073/pnas.0504978102 10.1128/AEM.66.5.2263-2266.2000 |
ContentType | Journal Article |
Copyright | Copyright © 2014 Crohn's & Colitis Foundation of America, Inc. 2014 Copyright © 2014 Crohn's & Colitis Foundation of America, Inc. |
Copyright_xml | – notice: Copyright © 2014 Crohn's & Colitis Foundation of America, Inc. 2014 – notice: Copyright © 2014 Crohn's & Colitis Foundation of America, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7T5 H94 |
DOI | 10.1097/MIB.0000000000000129 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE ProQuest One Academic Middle East (New) AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1536-4844 |
EndPage | 1501 |
ExternalDocumentID | 25072500 10_1097_MIB_0000000000000129 10.1097/MIB.0000000000000129 |
Genre | Research Support, Non-U.S. Gov't Journal Article Observational Study |
GroupedDBID | --- .Z2 0R~ 1OC 3WU 48X 53G 5GY 5VS 5WD 66C 7O~ 8-0 8UM AAAXR AABZA AACZT AAKAS AAPQZ AAPXW AARHZ AARTV AAUAY AAVAP AAYEP ABBUW ABDFA ABEJV ABGNP ABJNI ABNHQ ABOCM ABPQP ABPTD ABQNK ABVGC ABWST ABXVJ ABXVV ABZAD ACDDN ACEWG ACGFO ACGFS ACUTJ ACWDW ACWRI ACXNZ ACYHN ADBBV ADBIZ ADGZP ADIPN ADQBN ADRTK ADVEK ADZCM AENEX AETBJ AFFZL AFOFC AFTRI AFUWQ AFXAL AGINJ AGQXC AGUTN AHMBA AHMMS AIJEX AIZYK AJEEA ALMA_UNASSIGNED_HOLDINGS ATGXG AWKKM BAYMD BCRHZ BEYMZ BOYCO BTRTY C45 CDBKE CS3 DAKXR DR2 DU5 E.X E3Z EBS EJD ENERS EX3 F5P FECEO FL- FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H0~ HZ~ IN~ IX1 KBUDW KOP KSI KSN LAW MHKGH NNB NOMLY NOYVH NVLIB N~7 N~B O9- OAUYM OCZFY ODMLO OIG OJZSN OPAEJ OVD OWPYF P2P PAFKI PQQKQ QRW ROX RUSNO RX1 S4S TEORI V2E WOW XV2 YAYTL YKOAZ YXANX ZFV 31~ 4.4 7X7 8-1 88E 8F7 8FI 8FJ AAJQQ AAPGJ AAUQX AAWDT AAYXX ABUWG ACFRR ACVCV ACXQS ACZBC ADMTO ADNBA AEMQT AFBPY AFFQV AFKRA AFYAG AFZJQ AGKRT AGMDO AGORE AHGBF AHRYX AJAOE AJBYB AJDVS AJNCP AJNYG ALXQX APJGH AQDSO AQKUS AVNTJ BENPR CCPQU CITATION EIHJH FYUFA H13 HMCUK IAO IHR ITC JXSIZ LH4 LW6 M1P MBLQV NU- OBFPC OCUKA ORVUJ PHGZM PHGZT PSQYO ROL TMA UKHRP W99 WOQ Y6R CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 7T5 H94 |
ID | FETCH-LOGICAL-c408t-bfda493ee82b8c714b8571f6673aacf3bd3ad8c1ab5c794b96483bc2a4d61edc3 |
IEDL.DBID | 7X7 |
ISSN | 1078-0998 1536-4844 |
IngestDate | Fri Jul 11 02:57:49 EDT 2025 Wed Jul 30 11:23:21 EDT 2025 Fri Jul 25 21:51:43 EDT 2025 Wed Feb 19 02:41:17 EST 2025 Thu Apr 24 23:09:47 EDT 2025 Tue Jul 01 04:19:46 EDT 2025 Sat Feb 08 08:13:09 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | fluorescence in situ hybridization metabolic syndrome intestinal microbiota smoking cessation inflammatory bowel disease |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c408t-bfda493ee82b8c714b8571f6673aacf3bd3ad8c1ab5c794b96483bc2a4d61edc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
PMID | 25072500 |
PQID | 3169799947 |
PQPubID | 996336 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1680458953 proquest_miscellaneous_1553708087 proquest_journals_3169799947 pubmed_primary_25072500 crossref_citationtrail_10_1097_MIB_0000000000000129 crossref_primary_10_1097_MIB_0000000000000129 oup_primary_10_1097_MIB_0000000000000129 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-09-01 |
PublicationDateYYYYMMDD | 2014-09-01 |
PublicationDate_xml | – month: 09 year: 2014 text: 2014-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England – name: Baltimore |
PublicationTitle | Inflammatory bowel diseases |
PublicationTitleAlternate | Inflamm Bowel Dis |
PublicationYear | 2014 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Beaugerie (R22-2-20140815) 2001; 96 Kassinen (R12-2-20140815) 2007; 133 Manz (R33-2-20140815) 1996; 142 Bibiloni (R40-2-20140815) 2006; 55 Wallner (R31-2-20140815) 1993; 14 Dethlefsen (R17-2-20140815) 2011; 108 Franks (R28-2-20140815) 1998; 64 Benjamin (R39-2-20140815) 2012; 18 Ley (R3-2-20140815) 2005; 102 Joossens (R41-2-20140815) 2011; 60 Cosnes (R20-2-20140815) 1996; 110 Amann (R30-2-20140815) 1990; 172 Qin (R7-2-20140815) 2012; 490 Moter (R47-2-20140815) 2000; 41 Sghir (R36-2-20140815) 2000; 66 Berer (R9-2-20140815) 2011; 479 Amann (R27-2-20140815) 2008; 6 Mouzaki (R8-2-20140815) 2013; 58 Dethlefsen (R18-2-20140815) 2008; 6 Karlsson (R6-2-20140815) 2013; 498 Pace (R1-2-20140815) 1997; 276 (R15-2-20140815) 2012; 486 Koren (R10-2-20140815) 2011; 108 Langendijk (R34-2-20140815) 1995; 61 Mahid (R21-2-20140815) 2006; 81 OHara (R23-2-20140815) 1998; 148 Vijay-Kumar (R5-2-20140815) 2010; 328 Turnbaugh (R2-2-20140815) 2006; 444 Codling (R11-2-20140815) 2010; 55 Rodin (R25-2-20140815) 1987; 12 Seksik (R13-2-20140815) 2009; 15 Roller (R35-2-20140815) 1994; 140 Harmsen (R29-2-20140815) 2002; 68 Backhed (R4-2-20140815) 2004; 101 Manichanh (R43-2-20140815) 2006; 55 Faith (R16-2-20140815) 2013; 341 |
References_xml | – volume: 6 start-page: e280 year: 2008 ident: R18-2-20140815 publication-title: PLoS Biol doi: 10.1371/journal.pbio.0060280 – volume: 110 start-page: 424 year: 1996 ident: R20-2-20140815 publication-title: Gastroenterology doi: 10.1053/gast.1996.v110.pm8566589 – volume: 6 start-page: 339 year: 2008 ident: R27-2-20140815 publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro1888 – volume: 55 start-page: 205 year: 2006 ident: R43-2-20140815 publication-title: Gut doi: 10.1136/gut.2005.073817 – volume: 15 start-page: 734 year: 2009 ident: R13-2-20140815 publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.20828 – volume: 341 start-page: 1237439 year: 2013 ident: R16-2-20140815 publication-title: Science doi: 10.1126/science.1237439 – volume: 133 start-page: 24 year: 2007 ident: R12-2-20140815 publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.04.005 – volume: 14 start-page: 136 year: 1993 ident: R31-2-20140815 publication-title: Cytometry doi: 10.1002/cyto.990140205 – volume: 490 start-page: 55 year: 2012 ident: R7-2-20140815 publication-title: Nature doi: 10.1038/nature11450 – volume: 61 start-page: 3069 year: 1995 ident: R34-2-20140815 publication-title: Appl Environ Microbiol doi: 10.1128/AEM.61.8.3069-3075.1995 – volume: 68 start-page: 2982 year: 2002 ident: R29-2-20140815 publication-title: Appl Environ Microbiol doi: 10.1128/AEM.68.6.2982-2990.2002 – volume: 486 start-page: 207 year: 2012 ident: R15-2-20140815 publication-title: Nature doi: 10.1038/nature11234 – volume: 328 start-page: 228 year: 2010 ident: R5-2-20140815 publication-title: Science doi: 10.1126/science.1179721 – volume: 444 start-page: 1027 year: 2006 ident: R2-2-20140815 publication-title: Nature doi: 10.1038/nature05414 – volume: 55 start-page: 392 year: 2010 ident: R11-2-20140815 publication-title: Dig Dis Sci doi: 10.1007/s10620-009-0934-x – volume: 148 start-page: 821 year: 1998 ident: R23-2-20140815 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a009706 – volume: 55 start-page: 1141 year: 2006 ident: R40-2-20140815 publication-title: J Med Microbiol doi: 10.1099/jmm.0.46498-0 – volume: 108 start-page: 4554 year: 2011 ident: R17-2-20140815 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1000087107 – volume: 18 start-page: 1092 year: 2012 ident: R39-2-20140815 publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.21864 – volume: 64 start-page: 3336 year: 1998 ident: R28-2-20140815 publication-title: Appl Environ Microbiol doi: 10.1128/AEM.64.9.3336-3345.1998 – volume: 140 start-page: 2849 year: 1994 ident: R35-2-20140815 publication-title: Microbiology doi: 10.1099/00221287-140-10-2849 – volume: 96 start-page: 2113 year: 2001 ident: R22-2-20140815 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2001.03944.x – volume: 41 start-page: 85 year: 2000 ident: R47-2-20140815 publication-title: J Microbiol Methods doi: 10.1016/S0167-7012(00)00152-4 – volume: 108 start-page: 4592 year: 2011 ident: R10-2-20140815 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1011383107 – volume: 276 start-page: 734 year: 1997 ident: R1-2-20140815 publication-title: Science doi: 10.1126/science.276.5313.734 – volume: 142 start-page: 1097 year: 1996 ident: R33-2-20140815 publication-title: Microbiology doi: 10.1099/13500872-142-5-1097 – volume: 12 start-page: 303 year: 1987 ident: R25-2-20140815 publication-title: Addict Behav doi: 10.1016/0306-4603(87)90045-1 – volume: 479 start-page: 538 year: 2011 ident: R9-2-20140815 publication-title: Nature doi: 10.1038/nature10554 – volume: 172 start-page: 762 year: 1990 ident: R30-2-20140815 publication-title: J Bacteriol doi: 10.1128/jb.172.2.762-770.1990 – volume: 58 start-page: 120 year: 2013 ident: R8-2-20140815 publication-title: Hepatology doi: 10.1002/hep.26319 – volume: 101 start-page: 15718 year: 2004 ident: R4-2-20140815 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0407076101 – volume: 498 start-page: 99 year: 2013 ident: R6-2-20140815 publication-title: Nature doi: 10.1038/nature12198 – volume: 81 start-page: 1462 year: 2006 ident: R21-2-20140815 publication-title: Mayo Clin Proc doi: 10.4065/81.11.1462 – volume: 60 start-page: 631 year: 2011 ident: R41-2-20140815 publication-title: Gut doi: 10.1136/gut.2010.223263 – volume: 102 start-page: 11070 year: 2005 ident: R3-2-20140815 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0504978102 – volume: 66 start-page: 2263 year: 2000 ident: R36-2-20140815 publication-title: Appl Environ Microbiol doi: 10.1128/AEM.66.5.2263-2266.2000 |
SSID | ssj0020209 |
Score | 2.4820778 |
Snippet | There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating... BackgroundThere has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors... Background: There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors... |
SourceID | proquest pubmed crossref oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1496 |
SubjectTerms | Actinobacteria Bacteroides Clostridium coccoides Clostridium leptum Colony Count, Microbial DNA, Bacterial - genetics Eubacterium rectale Feces - microbiology Firmicutes Humans In Situ Hybridization, Fluorescence - methods Intestines - microbiology Microbiota Oligonucleotide Probes Prevotella Proteobacteria Smoking Cessation |
Title | Smoking Cessation Alters Intestinal Microbiota: Insights from Quantitative Investigations on Human Fecal Samples Using FISH |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25072500 https://www.proquest.com/docview/3169799947 https://www.proquest.com/docview/1553708087 https://www.proquest.com/docview/1680458953 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dT9swED8xkNBeJmCDdUBlpD3sJaKpndjhBVGgKkhFWwtS3yJ_RULaUiDt0_557vLRsiEVIuUhiWNZvjv77n7nO4DvqGF3RBaJgAs0UYSWSWC6MgtCL12UCS61I9fA8CYe3InrSTSpHW5FHVbZrInlQu2mlnzkxzyMCYFKhDx9eAyoahShq3UJjQ-wQanLKKRLTpYGV6cK8UALhyD-RDVH5xJ5PLzqVakLmysslczl1vTPcbdXWme5-_S34FOtNrKzis7bsObzHdgc1sD4Z_g7_jMlpzc7p5ImNNnsjHDwgpHLD8WY_h7eV1mXZvoEXxdklheMzpewX3Odl6fNcO1jL1JvIEsy7Kr09LO-R3qysaZ8wgUrYw1Y_2o8-AJ3_cvb80FQ11UIrOioWWAyp0XCvVddo6wMhVGRDDMqAKq1zbhxXDtlQ20ii-JqklgobmxXCxeH3lm-C-v5NPdfgWmO5o-nzowT3BmTxdaiBSiU8HGUhS3gzZSmtk46TrUvfqcN-I2ESP8nRAuCxV8PVdKNN9r_QGq9s-lBQ9K0ltYiXfJWC44Wn1HOCDzRuZ_Oi5TqK0lUr9WqNrEi3DmJeAv2KnZZDApVTYl359vqAezDR1TJRBXFdgDrs6e5P0S1Z2baJW-3YaN3efNzhE8Xo-4zBFf8bw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB_qFdQX8aPqabUrKPQl9JLdZDeCSFt73NnmUK-FvqX7FRDaXDV3iPg_-Tc6k4-rVqi-NJCXZHcJmdnZmfnNB8BL1LAHoohFwAWaKELLNDCRLILQSxcXgkvtyDWQTZLRkXh_HB-vwM8uF4bCKjuZWAtqN7PkI9_iYUIIVCrk2_MvAXWNInS1a6HRsMW-__4NTbbqzfgd0vdVFA33DndHQdtVILBioOaBKZwWKfdeRUZZGQqjYhkW1P5Sa1tw47h2yobaxBaZ1aSJUNzYSAuXhN5ZjuvegFXB0ZTpwerO3uTDp6WJN2iCStCmoqCCVHXJeqncysY7TbHE7gprtfbiMPwjwe4vPbc-74Z34U6rqLLthrPuwYov78PNrIXiH8CP6dmM3Oxsl5qoEHnZNiHvFSMnIwoOmp19buo8zfVrfFyRI6BilNHCPi50Wee3obRlvxX7wE3AcKkaW2BDjxzEppoqGFesjm5gw_F0tAZH1_LPH0KvnJX-MTDN0eDytJhxgjtjisRatDmFEj6Ji7APvPuluW3LnFO3jdO8g9uREPllQvQhWM46b8p8_GP8JlLrP4eudyTNW_lQ5Rfc3IcXy9e4swmu0aWfLaqcOjpJVOjVVWMSRUh3GvM-PGrYZflRqNxKvAdPrv6ADbg1OswO8oPxZP8p3EaFUDQxdOvQm39d-GeodM3N85bTGZxc9-b6Bdu-OkQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Smoking+Cessation+Alters+Intestinal+Microbiota%3A+Insights+from+Quantitative+Investigations+on+Human+Fecal+Samples+Using+FISH&rft.jtitle=Inflammatory+bowel+diseases&rft.au=Biedermann%2C+Luc&rft.au=Br%C3%BClisauer%2C+Karin&rft.au=Zeitz%2C+Jonas&rft.au=Frei%2C+Pascal&rft.date=2014-09-01&rft.pub=Oxford+University+Press&rft.issn=1078-0998&rft.eissn=1536-4844&rft.volume=20&rft.issue=9&rft.spage=1496&rft.epage=1501&rft_id=info:doi/10.1097%2FMIB.0000000000000129&rft.externalDocID=10.1097%2FMIB.0000000000000129 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0998&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0998&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0998&client=summon |